NO20092115L - Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on - Google Patents
Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-onInfo
- Publication number
- NO20092115L NO20092115L NO20092115A NO20092115A NO20092115L NO 20092115 L NO20092115 L NO 20092115L NO 20092115 A NO20092115 A NO 20092115A NO 20092115 A NO20092115 A NO 20092115A NO 20092115 L NO20092115 L NO 20092115L
- Authority
- NO
- Norway
- Prior art keywords
- octahydrobenzo
- isoxazol
- benzyl
- methyl
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Den foreliggende oppfinnelse vedrører oksalatsaltet av forbindelsen med formel 1 i alle dets stereokjemiske konfigurasjoner, en fremgangsmåte for dets fremstilling og dets anvendelse ved behandling av sinnstemningsforstyrrelser, angstforstyrrelser, depresjon og krampetilstander, ved forbedring av læreevne, ved reversering av amnesi, ved å løse abstinenssyndrom fra droger og drogemisbruk. Fortrinnsvis vedrører oppfinnelsen oksalatsaltet av rel-(3R,3aS,7aS)-3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002102A ITMI20062102A1 (it) | 2006-11-02 | 2006-11-02 | Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one |
PCT/IB2007/003292 WO2008053326A1 (en) | 2006-11-02 | 2007-10-31 | A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092115L true NO20092115L (no) | 2009-05-29 |
Family
ID=39145485
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092115A NO20092115L (no) | 2006-11-02 | 2009-05-29 | Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on |
NO20092114A NO20092114L (no) | 2006-11-02 | 2009-05-29 | Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092114A NO20092114L (no) | 2006-11-02 | 2009-05-29 | Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on |
Country Status (20)
Country | Link |
---|---|
US (2) | US20100069451A1 (no) |
EP (2) | EP2094674B1 (no) |
JP (2) | JP2010509310A (no) |
KR (2) | KR20090077014A (no) |
CN (2) | CN101535281A (no) |
AT (2) | ATE504578T1 (no) |
AU (2) | AU2007315833A1 (no) |
BR (2) | BRPI0718392A2 (no) |
CA (2) | CA2667515A1 (no) |
DE (2) | DE602007013801D1 (no) |
HR (2) | HRP20090470A2 (no) |
IL (2) | IL198444A0 (no) |
IT (1) | ITMI20062102A1 (no) |
MX (2) | MX2009004293A (no) |
NO (2) | NO20092115L (no) |
NZ (2) | NZ577311A (no) |
RS (2) | RS20090388A (no) |
RU (2) | RU2009120724A (no) |
WO (2) | WO2008053325A1 (no) |
ZA (2) | ZA200903618B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2112142A1 (en) * | 2008-04-24 | 2009-10-28 | Abiogen Pharma S.p.A. | Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
ITMI20080768A1 (it) * | 2008-04-24 | 2009-10-25 | Abiogen Pharma Spa | Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one |
EP2218721A1 (en) * | 2009-02-11 | 2010-08-18 | LEK Pharmaceuticals d.d. | Novel salts of sitagliptin |
WO2011010332A1 (en) * | 2009-07-23 | 2011-01-27 | Abiogen Pharma S.P.A. | Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof |
WO2016123275A1 (en) * | 2015-01-30 | 2016-08-04 | Boehringer Ingelheim International Gmbh | Aldosterone synthase inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4161595A (en) * | 1978-10-02 | 1979-07-17 | Bristol-Myers Company | Levulinic acid salt |
US4419358A (en) * | 1981-11-12 | 1983-12-06 | Mead Johnson & Company | Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it |
GB2264299B (en) * | 1992-02-19 | 1995-07-26 | British Tech Group | Iso-oxazolidine derivatives |
-
2006
- 2006-11-02 IT IT002102A patent/ITMI20062102A1/it unknown
-
2007
- 2007-10-31 MX MX2009004293A patent/MX2009004293A/es not_active Application Discontinuation
- 2007-10-31 AT AT07825550T patent/ATE504578T1/de not_active IP Right Cessation
- 2007-10-31 NZ NZ577311A patent/NZ577311A/en unknown
- 2007-10-31 RU RU2009120724/04A patent/RU2009120724A/ru not_active Application Discontinuation
- 2007-10-31 DE DE602007013801T patent/DE602007013801D1/de active Active
- 2007-10-31 KR KR1020097011287A patent/KR20090077014A/ko not_active Application Discontinuation
- 2007-10-31 EP EP07825549A patent/EP2094674B1/en not_active Not-in-force
- 2007-10-31 KR KR1020097011322A patent/KR20090082452A/ko not_active Application Discontinuation
- 2007-10-31 EP EP07825550A patent/EP2094675B1/en not_active Not-in-force
- 2007-10-31 NZ NZ577978A patent/NZ577978A/en unknown
- 2007-10-31 RU RU2009120667/04A patent/RU2009120667A/ru not_active Application Discontinuation
- 2007-10-31 JP JP2009535825A patent/JP2010509310A/ja active Pending
- 2007-10-31 RS RSP-2009/0388A patent/RS20090388A/sr unknown
- 2007-10-31 CN CNA2007800406598A patent/CN101535281A/zh active Pending
- 2007-10-31 BR BRPI0718392-5A patent/BRPI0718392A2/pt not_active IP Right Cessation
- 2007-10-31 US US12/513,352 patent/US20100069451A1/en not_active Abandoned
- 2007-10-31 JP JP2009535824A patent/JP2010509309A/ja active Pending
- 2007-10-31 AT AT07825549T patent/ATE502021T1/de not_active IP Right Cessation
- 2007-10-31 AU AU2007315833A patent/AU2007315833A1/en not_active Abandoned
- 2007-10-31 DE DE602007013278T patent/DE602007013278D1/de active Active
- 2007-10-31 CN CNA2007800406691A patent/CN101535282A/zh active Pending
- 2007-10-31 AU AU2007315832A patent/AU2007315832A1/en not_active Abandoned
- 2007-10-31 CA CA002667515A patent/CA2667515A1/en not_active Abandoned
- 2007-10-31 WO PCT/IB2007/003291 patent/WO2008053325A1/en active Application Filing
- 2007-10-31 MX MX2009004294A patent/MX2009004294A/es not_active Application Discontinuation
- 2007-10-31 US US12/513,351 patent/US20100069450A1/en not_active Abandoned
- 2007-10-31 BR BRPI0718391-7A patent/BRPI0718391A2/pt not_active IP Right Cessation
- 2007-10-31 RS RSP-2009/0389A patent/RS20090389A/sr unknown
- 2007-10-31 CA CA002667513A patent/CA2667513A1/en not_active Abandoned
- 2007-10-31 WO PCT/IB2007/003292 patent/WO2008053326A1/en active Application Filing
-
2009
- 2009-04-28 IL IL198444A patent/IL198444A0/en unknown
- 2009-04-28 IL IL198443A patent/IL198443A0/en unknown
- 2009-05-25 ZA ZA200903618A patent/ZA200903618B/xx unknown
- 2009-05-29 NO NO20092115A patent/NO20092115L/no not_active Application Discontinuation
- 2009-05-29 NO NO20092114A patent/NO20092114L/no not_active Application Discontinuation
- 2009-06-01 ZA ZA200903810A patent/ZA200903810B/xx unknown
- 2009-09-03 HR HR20090470A patent/HRP20090470A2/hr not_active Application Discontinuation
- 2009-09-08 HR HR20090477A patent/HRP20090477A2/hr not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0303180D0 (sv) | Novel compounds | |
ATE542818T1 (de) | Imidazo- und triazolopyridinverbindungen und verfahren zu deren anwendung | |
DE602006021645D1 (de) | Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten | |
SE0201635D0 (sv) | Novel compounds | |
ECSP055910A (es) | Nuevos acidos carboxilicos y sus esteres, medicamentos que contienen estos compuestos y procedimientos para su preparacion | |
EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
TW200700068A (en) | Phthalazine, aza-and diaza-phthalazine compounds and methods of use | |
MA29135B1 (fr) | Potentialisateurs de recepteurs du glutamate | |
NO20092114L (no) | Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on | |
CY1108880T1 (el) | Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
ATE318813T1 (de) | Neue kristalline formen von meloxicam, deren herstellung und verfahren zu deren umwandlung ineinander | |
EA200701856A1 (ru) | Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении | |
ATE502945T1 (de) | Ä ä5- ( phenyl) - 6- phenylpyrrolo ä2,1-füä2,1, 4ütriazin-4-ylüaminoü carbonsäurederivate und verwandte verbindungen als prostazyklin (pgi2) ip-rezeptor aktivatoren zur behandlung von kardiovaskulären erkrankungen | |
ATE354583T1 (de) | Verfahren zur herstellung c-7 substituierter 5- androstene | |
NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
PL2186782T3 (pl) | Sposób oczyszczania produktów znakowanych radioaktywnie z zastosowaniem zmiatacza na stałym nośniku | |
EA200600563A1 (ru) | Способ получения рензаприда и его промежуточных соединений | |
DK1873152T3 (da) | Hidtil ukendt fremgangsmåde til oprensning af Moxonidin | |
ATE481408T1 (de) | Reinigung von beta-lactam-verbindungen | |
EA200602082A1 (ru) | Производные индол-2-она для лечения расстройств центральной нервной системы, желудочно-кишечных расстройств и сердечно-сосудистых расстройств | |
EA200602080A1 (ru) | Пиперазиновые производные алкилоксиндолов | |
SE0303451D0 (sv) | New compounds | |
TH82183B (th) | อนุพันธ์ของไดไฮโดรเบนโซฟูรานและการใช้อนุพันธ์สารชนิดนี้ | |
TH77909A (th) | พิเพอราซีนที่มีการแทนที่-OR สำหรับ GlyT1 | |
TH87148A (th) | สารยับยั้งไทโรซีนไคเนส |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |